Patient characteristics and eligibility for biologics in severe asthma: Results from the Greek cohort of the RECOGNISE "real world" study.

Saved in:
Bibliographic Details
Title: Patient characteristics and eligibility for biologics in severe asthma: Results from the Greek cohort of the RECOGNISE "real world" study.
Authors: Bakakos P; 1st Academic Department of Respiratory Medicine, SOTIRIA General Hospital for Thoracic Diseases, National and Kapodistrian University of Athens, Athens, Greece., Tryfon S; Pulmonary Department (NHS), 'G Papanikolaou' General Hospital, Thessaloniki, Greece., Palamidas A; Private Practice, Scientific Partner at Athens Medical Center, Athens, Greece., Mathioudakis N; Medical Department Respiratory & Immunology AstraZeneca, Athens, Greece., Galanakis P; Medical Department Respiratory & Immunology AstraZeneca, Athens, Greece. Electronic address: petros44@hotmail.com.
Source: Respiratory medicine [Respir Med] 2023 Apr-May; Vol. 210, pp. 107170. Date of Electronic Publication: 2023 Feb 24.
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
Journal Info: Publisher: Elsevier Country of Publication: England NLM ID: 8908438 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1532-3064 (Electronic) Linking ISSN: 09546111 NLM ISO Abbreviation: Respir Med Subsets: MEDLINE
Database: MEDLINE Ultimate
Description
ISSN:1532-3064
DOI:10.1016/j.rmed.2023.107170